Emodin Sensitizes Hepatocellular Carcinoma Cells to the Anti-Cancer Effect of Sorafenib through Suppression of Cholesterol Metabolism

@article{Kim2018EmodinSH,
  title={Emodin Sensitizes Hepatocellular Carcinoma Cells to the Anti-Cancer Effect of Sorafenib through Suppression of Cholesterol Metabolism},
  author={Young-Seon Kim and Yoon-Mi Lee and Taek-In Oh and D. H. Shin and G. Kim and S. Kan and Hyeji Kang and J. Kim and Byeong Mo Kim and Woo jong Yim and Ji-Hong Lim},
  journal={International Journal of Molecular Sciences},
  year={2018},
  volume={19}
}
  • Young-Seon Kim, Yoon-Mi Lee, +8 authors Ji-Hong Lim
  • Published 2018
  • Chemistry, Medicine
  • International Journal of Molecular Sciences
  • Reduced therapeutic efficacy of sorafenib, a first-generation multikinase inhibitor, is often observed during the treatment of advanced hepatocellular carcinoma (HCC). Emodin is an active component of Chinese herbs, and is effective against leukemia, lung cancer, colon cancer, pancreatic cancer, and HCC; however, the sensitizing effect of emodin on sorafenib-based HCC therapy has not been evaluated. Here, we demonstrate that emodin significantly improved the anti-cancer effect of sorafenib in… CONTINUE READING
    19 Citations
    Oridonin Sensitizes Hepatocellular Carcinoma to the Anticancer Effect of Sorafenib by Targeting the Akt Pathway
    • PDF
    Ursolic Acid Suppresses Cholesterol Biosynthesis and Exerts Anti-Cancer Effects in Hepatocellular Carcinoma Cells
    • 6
    • PDF
    Sorafenib-Induced Apoptosis in Hepatocellular Carcinoma Is Reversed by SIRT1
    • 12
    • PDF
    Gold nanoparticles-loaded anti-miR221 enhances antitumor effect of sorafenib in hepatocellular carcinoma cells
    • 3
    • PDF
    Thymoquinone Selectively Kills Hypoxic Renal Cancer Cells by Suppressing HIF-1α-Mediated Glycolysis
    • 6
    • PDF
    Targeting SREBP-2-Regulated Mevalonate Metabolism for Cancer Therapy
    • 2
    • PDF
    Cinobufagin Suppresses Melanoma Cell Growth by Inhibiting LEF1
    • 1
    • PDF
    Is the era of sorafenib over? A review of the literature
    • 4

    References

    SHOWING 1-10 OF 50 REFERENCES
    AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC).
    • 89
    Synergistic anti-tumor efficacy of sorafenib and fluvastatin in hepatocellular carcinoma
    • 15
    • PDF
    Sorafenib and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma
    • 119
    Emodin induces hepatocellular carcinoma cell apoptosis through MAPK and PI3K/AKT signaling pathways in vitro and in vivo.
    • 26
    • PDF